Functional and morphological characterization of glutamate transporters in the rat locus coeruleus

British Journal of Pharmacology

Volumn 169, Issue 8, 2013, Pages 1781-1794

  Medrano, M C ^a   Gerrikagoitia, I ^a   Martinez Millan L ^a   Mendiguren, A ^a   Pineda, J ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

EAAT2; EAAT3; firing; glutamate; KCl; locus coeruleus

Indexed keywords

2,4 PYRROLIDINEDICARBOXYLIC ACID; AMPA RECEPTOR; ASPARTIC ACID DERIVATIVE; CEFTRIAXONE; DIHYDROKAINIC ACID; EXCITATORY AMINO ACID TRANSPORTER; EXCITATORY AMINO ACID TRANSPORTER 2; EXCITATORY AMINO ACID TRANSPORTER 3; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; IONOTROPIC RECEPTOR; METABOTROPIC RECEPTOR; POTASSIUM CHLORIDE; THREO BETA BENZYLOXASPARTIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; GLIA CELL; IMMUNOHISTOCHEMISTRY; LOCUS CERULEUS; MALE; NERVE CELL; NERVE CELL STIMULATION; NONHUMAN; NORADRENERGIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; RAT; UPREGULATION;

EAAT2; EAAT3; FIRING; GLUTAMATE; KCL; LOCUS COERULEUS;

ADRENERGIC NEURONS; ANIMALS; CEFTRIAXONE; EXCITATORY AMINO ACID TRANSPORTER 2; EXCITATORY AMINO ACID TRANSPORTER 3; GLUTAMINE; KAINIC ACID; LOCUS COERULEUS; MALE; NEUROGLIA; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84881351697     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12235     Document Type: Article

References (57)

1. Aghajanian GK, Kogan JH, Moghaddam B, (1994). Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study. Brain Res 636: 126-130.
2. Albo F, Pieri M, Zona C, (2004). Modulation of AMPA receptors in spinal motor neurons by the neuroprotective agent riluzole. J Neurosci Res 78: 200-207.
3. Alexander SPH, Mathie A, Peters JA, (2011). Guide to receptors and channels (GRAC), 5th edition. Br J Pharmacol 164 (Suppl. 1): S1-S324.
4. Alreja M, Aghajanian GK, (1995). Intracellular application of macromolecules through patch pipettes in brain slices. In:, Schurr A, Rigor BM, (eds). Brain Slices in Basic and Clinical Research. CRC Press: London, pp. 117-130.
5. Amara SG, Fontana ACK, (2002). Excitatory amino acid transporters: keeping up with glutamate. Neurochem Intern 41: 313-318.
6. Andrade R, Aghajanian GK, (1984). Locus coeruleus activity in vitro: intrinsic regulation by a calcium- dependent potassium conductance but not alpha 2-adrenoceptors. J Neurosci 4: 161-170.
7. Aston-Jones G, (2005). Brain structures and receptors involved in alertness. Sleep Med 6 (Suppl. 1): S3-S7.
8. Aston-Jones G, Cohen JD, (2005). Adaptive gain and the role of the locus coeruleus-norepinephrine system in optimal performance. J Comp Neurol 493: 99-110.
9. Aston-Jones G, Ennis M, Pieribone VA, Nickell WT, Shipley MT, (1986). The brain nucleus locus coeruleus: restricted afferent control of a broad efferent network. Science 234: 734-737.
10. Berger UV, Hediger MA, (1998). Comparative analysis of glutamate transporter expression in rat brain using differential double in situ hybridization. Anat Embryol (Berl) 198: 13-30.
11. Berridge CW, Waterhouse BD, (2003). The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Rev 42: 33-84.
12. Bridges RJ, Esslinger CS, (2005). The excitatory amino acid transporters: pharmacological insights on substrate and inhibitor specificity of the EAAT subtypes. Pharmacol Ther 107: 271-285.
13. Bunch L, Krogsgaard-Larsen P, (2009). Subtype selective kainic acid receptor agonists: discovery and approaches to rational design. Med Res Rev 29: 3-28.
14. Bunch L, Erichsen MN, Jensen AA, (2009). Excitatory amino acid transporters as potential drug targets. Expert Opin Ther Targets 13: 719-731.
15. Cherubini E, North RA, Williams JT, (1988). Synaptic potentials in rat locus coeruleus neurones. J Physiol 406: 431-442.
16. Danbolt NC, (2001). Glutamate uptake. Prog Neurobiol 65: 1-105.
17. Dubé GR, Marshall KC, (1997). Modulation of excitatory synaptic transmission in locus coeruleus by multiple presynaptic metabotropic glutamate receptors. Neuroscience 80: 511-521.
18. Ennis M, Aston-Jones G, Shiekhattar R, (1992). Activation of locus coeruleus neurons by nucleus paragigantocellularis or noxious sensory stimulation is mediated by intracoerulear excitatory amino acid neurotransmission. Brain Res 598: 185-195.
19. Fairman WA, Vandenberg RJ, Arriza JL, Kavanaugh MP, Amara SG, (1995). An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature 375: 599-603.
20. Fujio M, Nakagawa T, Sekiya Y, (2005). Gene transfer of GLT-1, a glutamate transporter, into the nucleus accumbens shell attenuates methamphetamine- and morphine-induced conditioned place preference in rats. Eur J Neurosci 22: 2744-2754.
21. Furuta A, Martin LJ, Lin CL, Dykes-Hoberg M, Rothstein JD, (1997). Cellular and synaptic localization of the neuronal glutamate transporters excitatory amino acid transporter 3 and 4. Neuroscience 81: 1031-1042.
22. He Y, Janssen WG, Rothstein JD, Morrison JH, (2000). Differential synaptic localization of the glutamate transporter EAAC1 and glutamate receptor subunit GluR2 in the rat hippocampus. J Comp Neurol 418: 255-269.
23. Jensen AA, Brauner-Osborne H, (2004). Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay. Biochem Pharmacol 67: 2115-2127.
24. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). NC3Rs Reporting Guidelines Working Group. Br J Pharmacol 160: 1577-1579.
25. Koob GF, Maldonado R, Stinus L, (1992). Neural substrates of opiate withdrawal. Trends Neurosci 15: 186-191.
26. Lee G, Huang Y, Washington JM, Briggs NW, Zuo Z, (2005). Carbamazepine enhances the activity of glutamate transporter type 3 via phosphatidylinositol 3-kinase. Epilepsy Res 66: 145-153.
27. Lee SG, Su ZZ, Emdad L, Gupta P, Sarkar D, Borjabad A, et al. (2008). Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes. J Biol Chem 283: 13116-13123.
28. Maki R, Robinson MB, Dichter MA, (1994). The Glutamate Uptake inhibitor L- Trans-pyrrolidine-2,4-dicarboxylate depresses excitatory synaptic transmission via a presynaptic mechanism in cultured hippocampal neurons. J Neurosci 14: 6754-6762.
29. McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
30. Mendiguren A, Pineda J, (2004). Cannabinoids enhance N-methyl-D- aspartate-induced excitation of locus coeruleus neurons by CB1 receptors in rat brain slices. Neurosci Lett 363: 1-5.
31. Mendiguren A, Pineda J, (2007). CB (1) cannabinoid receptors inhibit the glutamatergic component of KCl-evoked excitation of locus coeruleus neurons in rat brain slices. Neuropharmacology 52: 617-625.
32. Nakagawa T, Ozawa T, Shige K, Yamamoto R, Minami M, Satoh M, et al. (2001). Inhibition of morphine tolerance and dependence by MS-153, a glutamate transporter activator. Eur J Pharmacol 419: 39-45.
33. Nieoullon A, Canolle B, Masmejean F, Guillet B, Pisano P, Lortet S, (2006). The neuronal excitatory amino acid transporter EAAC1/EAAT3: does it represent a major actor at the brain excitatory synapse? J Neurochem 98: 1007-1018.
34. Olpe HR, Steinmann MW, Brugger F, Pozza MF, (1989). Excitatory amino acid receptors in rat locus coeruleus. An extracellular in vitro study. Naunyn Schmiedeberg's Arch Pharmacol 339: 312-315.
35. Ozawa T, Nakagawa T, Sekiya Y, Minami M, Satoh M, (2004). Effect of gene transfer of GLT-1, a glutamate transporter, into the locus coeruleus by recombinant adenoviruses on morphine physical dependence in rats. Eur J Neurosci 19: 221-226.
36. Petralia RS, Yokotani N, Wenthold RJ, (1994). Light and electron microscope distribution of the NMDA receptor subunit NMDAR1 in the rat nervous system using a selective anti-peptide antibody. J Neurosci 14: 667-696.
37. Rakhade SN, Loeb JA, (2008). Focal reduction of neuronal glutamate transporters in human neocortical epilepsy. Epilepsia 49: 226-236.
38. Rasmussen BA, Baron DA, Kim JK, Unterwald EM, Rawls SM, (2011). Beta-lactam antibiotic produces a sustained reduction in extracellular glutamate in the nucleus accumbens of rats. Amino Acids 40: 761-764.
39. Rasmussen K, Krystal JH, Aghajanian GK, (1991). Excitatory amino acids and morphine withdrawal: differential effects of central and peripheral kynurenic acid administration. Psychopharmacology (Berl) 105: 508-512.
40. Rawls SM, Baron DA, Kim J, (2010). Beta-Lactam antibiotic inhibits development of morphine physical dependence in rats. Behav Pharmacol 21: 161-164.
41. Rothstein JD, Martin L, Levey AI, Bristol LA, Jin L, Kuncl RW, et al. (1994). Localization of neuronal and glial glutamate transporters. Neuron 13: 713-725.
42. Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, et al. (2005). Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433: 73-77.
43. Ryu J, Cheong IY, Do SH, Zuo Z, (2009). Alphaxalone, a neurosteroid anaesthetic, increases the activity of the glutamate transporter type 3 expressed in Xenopus oocytes. Eur J Pharmacol 602: 23-27.
44. Sato K, Kiyama H, Tohyama M, (1993). The differential expression patterns of messenger RNAs encoding non-N-methyl-D-aspartate glutamate receptor subunits (GluR1-4) in the rat brain. Neuroscience 52: 515-539.
45. Sekiya Y, Nakagawa T, Ozawa T, Minami M, Satoh M, (2004). Facilitation of morphine withdrawal symptoms and morphine-induced conditioned place preference by a glutamate transporter inhibitor DL-threo-beta-benzyloxyaspartate in rats. Eur J Pharmacol 485: 201-210.
46. Sharifullina E, Nistri A, (2006). Glutamate uptake block triggers deadly rhythmic bursting of neonatal rat hypoglossal motoneurons. J Physiol 572: 407-423.
47. Shigeri Y, Shimamoto K, Yasuda-Kamatani Y, Seal RP, Yumoto N, Nakajima T, et al. (2001). Effects of threo-β-hydroxyaspartate derivatives on excitatory amino acid transporters (EAAT4 and EAAT5). J Neurochem 79: 297-302.
48. Shimamoto K, Lebrun B, Yasuda-Kamatani Y, Sakaitani M, Shigeri Y, Yumoto N, et al. (1998). DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters. Mol Pharmacol 53: 195-201.
49. Shimamoto K, Shigeri Y, Yasuda-Kamatani Y, Lebrun B, Yumoto N, Nakajima T, (2000). Syntheses of optically pure beta-hydroxyaspartate derivatives as glutamate transporter blockers. Bioorg Med Chem Lett 10: 2407-2410.
50. Singewald N, Philippu A, (1998). Release of neurotransmitters in the locus coeruleus. Prog Neurobiol 56: 237-267.
51. Thomson LM, Zeng J, Terman GW, (2006). Differential effect of glutamate transporter inhibition on EPSCs in the morphine näbox drawings light down and leftve and morphine tolerant neonatal spinal cord slice. Neurosci Lett 407: 64-69.
52. Torrecilla M, Ruiz-Ortega JA, Ugedo L, Pineda J, (2007). Excitatory regulation of noradrenergic neurons by L-arginine/nitric oxide pathway in the rat locus coeruleus in vivo. Naunyn Schmiedebergs Arch Pharmacol 375: 337-347.
53. Ugedo L, Garro MA, Pineda J, Giralt MT, Miralles A, Olmos G, et al. (1993). Acute and chronic effects of reserpine on biochemical and functional parameters of central and peripheral alpha 2-adrenoceptors. Eur J Pharmacol 239: 149-157.
54. Van Bockstaele EJ, Menko AS, Drolet G, (2001). Neuroadaptive responses in brainstem noradrenergic nuclei following chronic morphine exposure. Mol Neurobiol 23: 155-171.
55. Verma R, Mishra V, Sasmal D, Raghubir R, (2010). Pharmacological evaluation of glutamate transporter 1 (GLT-1) mediated neuroprotection following cerebral ischemia/reperfusion injury. Eur J Pharmacol 638: 65-71.
56. Wisden W, Seeburg PH, (1993). A complex mosaic of high-affinity kainate receptors in rat brain. J Neurosci 13: 38-44.
57. Zamalloa T, Bailey CP, Pineda J, (2009). Glutamate-induced post-activation inhibition of locus coeruleus neurons is mediated by AMPA/kainate receptors and sodium-dependent potassium currents. Br J Pharmacol 156: 649-661.